X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3488) 3488
Publication (342) 342
Newspaper Article (227) 227
Book Review (45) 45
Government Document (39) 39
Newsletter (31) 31
Book / eBook (24) 24
Magazine Article (24) 24
Dissertation (18) 18
Web Resource (17) 17
Book Chapter (14) 14
Trade Publication Article (10) 10
Conference Proceeding (5) 5
Reference (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3043) 3043
mammography (3031) 3031
female (2834) 2834
middle aged (1751) 1751
breast cancer (1678) 1678
index medicus (1407) 1407
adult (1288) 1288
aged (1195) 1195
cancer (1032) 1032
oncology (899) 899
breast neoplasms - diagnostic imaging (872) 872
risk factors (758) 758
women (732) 732
diagnosis (701) 701
mammography - adverse effects (697) 697
breast neoplasms - diagnosis (679) 679
risk (518) 518
breast neoplasms - pathology (472) 472
breast neoplasms - prevention & control (459) 459
breast neoplasms - epidemiology (457) 457
radiology, nuclear medicine & medical imaging (446) 446
mortality (443) 443
womens health (432) 432
research (431) 431
health aspects (426) 426
breast (425) 425
surgery (393) 393
medicine, general & internal (379) 379
medical screening (337) 337
breast neoplasms - etiology (332) 332
mass screening (326) 326
mammography - methods (324) 324
public, environmental & occupational health (319) 319
age factors (313) 313
breast neoplasms - mortality (312) 312
care and treatment (289) 289
medicine & public health (289) 289
risk assessment (285) 285
breast-cancer (282) 282
aged, 80 and over (281) 281
breast - pathology (275) 275
male (258) 258
screening (253) 253
biopsy (251) 251
mass screening - methods (243) 243
retrospective studies (238) 238
analysis (236) 236
obstetrics & gynecology (229) 229
cancer therapies (228) 228
united states (226) 226
sensitivity and specificity (223) 223
time factors (220) 220
patients (219) 219
prognosis (218) 218
incidence (216) 216
breast neoplasms - surgery (215) 215
epidemiology (215) 215
usage (214) 214
postmenopausal women (213) 213
studies (213) 213
follow-up studies (205) 205
age (204) 204
magnetic resonance imaging (204) 204
hormone replacement therapy (203) 203
follow-up (202) 202
estrogen replacement therapy - adverse effects (199) 199
abridged index medicus (198) 198
radiation dosage (192) 192
mass screening - adverse effects (188) 188
oncology, experimental (188) 188
health risk assessment (187) 187
menopause (187) 187
screening mammography (181) 181
article (178) 178
chemotherapy (176) 176
medicine (175) 175
mastectomy (173) 173
survival (173) 173
prevention (170) 170
false positive reactions (167) 167
tumors (167) 167
radiology (165) 165
breast neoplasms - therapy (163) 163
prospective studies (162) 162
public health (162) 162
early detection of cancer (160) 160
internal medicine (157) 157
carcinoma (156) 156
neoplasm staging (156) 156
medical research (155) 155
research article (154) 154
surveys and questionnaires (154) 154
treatment outcome (153) 153
breast neoplasms - genetics (149) 149
mammography - standards (149) 149
adolescent (139) 139
breast neoplasms - chemically induced (139) 139
estrogen (139) 139
postmenopause (139) 139
trial (139) 139
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3673) 3673
German (79) 79
French (38) 38
Spanish (17) 17
Danish (13) 13
Italian (13) 13
Russian (10) 10
Dutch (9) 9
Norwegian (8) 8
Swedish (8) 8
Japanese (7) 7
Polish (5) 5
Portuguese (3) 3
Chinese (2) 2
Hebrew (2) 2
Turkish (2) 2
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Health Expectations, ISSN 1369-6513, 04/2017, Volume 20, Issue 2, pp. 211 - 220
Background Cancer screening has contributed to downward trends in cancer mortality, but is also associated with adverse effects, which highlights the... 
early detection of cancer | health knowledge, attitudes, practice | neoplasm | health knowledge | MORTALITY | POPULATION | practice | attitudes | INFORMATION | KNOWLEDGE | PATTERNS | BREAST-CANCER | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PREDICTORS | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | HEALTH | OF-THE-LITERATURE | GENDER-DIFFERENCES | Prevalence | Early Detection of Cancer | Awareness | Humans | Middle Aged | Male | Neoplasms - diagnosis | Health Knowledge, Attitudes, Practice | Young Adult | Mass Screening | Adolescent | Portugal - epidemiology | Sex Factors | Adult | Female | Interviews as Topic | Poisson Distribution | Aged | Qualitative Research | Neoplasms - epidemiology | Prevention | Complications and side effects | Analysis | Mortality | Colorectal cancer | Diagnosis | Prostate cancer | Cancer | Lung cancer | Health psychology | Perceptions | Sex differences | Gender differences | Breast cancer | Medical screening | Patient compliance | Stomach cancer | Skin cancer | Confidence intervals | Screening | Side effects | Anxieties | Comparative studies | Cervical cancer | Colorectal carcinoma | Sex | Gender aspects | Population | Anxiety | Poisson density functions | Statistical analysis | Mammography | Cervix | Cellular biology | Lungs | Womens health | Men | Breast | Perception | Skin | Prostate | Original Research Papers | Original Research Paper
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 06/2013, Volume 10, Issue 6, pp. 304 - 304
Journal Article
Radiologic Clinics of North America, ISSN 0033-8389, 2004, Volume 42, Issue 5, pp. 807 - 819
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9816, pp. 633 - 640
Summary Background The anti-HER2 monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib have complementary mechanisms of action and... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | APOPTOSIS | CELLS | WOMEN | MEDICINE, GENERAL & INTERNAL | GW572016 | ERBB2 | INHIBITOR | PLUS | Breast Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Diarrhea - chemically induced | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Liver - drug effects | Adult | Female | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Paclitaxel - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Liver - metabolism | Paclitaxel - adverse effects | Treatment Outcome | Breast Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Quinazolines - adverse effects | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Drug therapy | Breast cancer | Genetic aspects | Medical research | Ligands | Cytotoxicity | Mammography | Kinases | Cancer therapies | pathology | Liver | methods | Antibodies | Oral | Quinazolines | Breast Neoplasms | Tumor Markers | administration & dosage | Surgery | Paclitaxel | Neoadjuvant Therapy | Adjuvant | Monoclonal | chemistry | Administration | drug therapy | chemically induced | Intravenous | Infusions | Humanized | Antineoplastic Combined Chemotherapy Protocols | Diarrhea | drug effects | Biological | analysis | Kirurgi | antagonists & inhibitors | Chemotherapy | Receptor | adverse effects | metabolism | Cancer and Oncology | therapeutic use | Cancer och onkologi | erbB-2
Journal Article
Journal Article